The Separate and Combined Effects of GIP, GLP-1, and GLP-2 on Markers of Bone Turnover in Type 2 Diabetes
Our findings suggest that postprandial suppression of bone resorption in individuals with T2D is mediated by the additive effects of GIP, GLP-1, and GLP-2.
Authors
- Tina Vilsbøll (ORCID: https://orcid.org/0000-0002-0456-6787)
- Mads M. Helsted (ORCID: https://orcid.org/0000-0001-6612-8080)
- Jonatan I. Bagger (ORCID: https://orcid.org/0000-0003-3174-1613)
- Mikkel Christensen (ORCID: https://orcid.org/0000-0002-8774-1797)
- Asger Lund (ORCID: https://orcid.org/0000-0003-1212-3764)
- Niklas Rye Jørgensen (ORCID: https://orcid.org/0000-0001-9624-5210)
- David S. Mathiesen (ORCID: https://orcid.org/0000-0002-3545-5721)
- Filip K. Knop (ORCID: https://orcid.org/0000-0002-2495-5034)
- Jens J. Holst (ORCID: https://orcid.org/0000-0001-6853-3805)
- John‐Erik Stig Hansen
Institutions
- University of Copenhagen (DK)
- Steno Diabetes Centers (DK)
- Novo Nordisk (Denmark) (DK)
- Novo Nordisk Foundation (DK)
- Frederiksberg Hospital (DK)
- Copenhagen University Hospital (DK)
- Gentofte Hospital (DK)
- Rigshospitalet (DK)
- Novo Nordisk (United States) (US)
Publication Details
- Journal
- The Journal of Clinical Endocrinology & Metabolism
- Published
- 2025-08-25
- DOI
- https://doi.org/10.1210/clinem/dgaf482
- Citations
- 1
- Primary Topic
- Metabolism, Diabetes, and Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.81
Funders
- Novo Nordisk
- Danmarks Frie Forskningsfond
- Diabetesforeningen